Tracks

Biotech 2010 will feature six tracks related to the bioscience industry in the mid Atlantic region, they include:

• Communications and Public Affairs
  • Walking the Razor's Edge: Disclosure, Transparency, and Reputation in the Era of Sunshine
  • Compliant Communication: Who's Listening (and Who's Talking)? What You Say Can be Held Against You
  • New Bioscience Entrepreneurs: The Strategy Behind Positioning for Investors and Partnering
     
• Finance
  • Deconstructing a Term Sheet: Financing Considerations for Earlier-Stage Companies
  • How Do the Buy-side and Sell-side Really Look at Companies?
  • Collaborations: Upfront Planning Can Pay Dividends
     
• Growth Strategies for Bioscience Companies
  • It’s All About the Exit: Strategies and Tactics
  • Regulatory Strategies for Growth
  • Alternative Business Models
     
• Hot Topics in Business
  • Global Collaboration: Opportunities in Emerging Markets
  • Commercialization Strategies for Development-Stage Companies
  • Health Care Reform: Bottom Line Perspectives
     
• Hot Topics in Science
  • New Approaches for Cancer Treatment: Targeting the Tumor Microenvironment
  • Synthetic Life – How Far Are We From Playing God?
  • Mimicking Nature: Who Will Win the Race – Tissue Regeneration or Artificial Organs?
     
• Korea BioBiz Opportunities
  • Investment Forum
  • Partnering with Korean Bio/Pharma Companies
     
• Medical Device, Diagnostics, and Drug Delivery
  • Is the 510(k) Review Really an Overhaul?
  • Reimbursement with a Global Flair: What You Need to Trek the Medical Device Reimbursement Landscape
  • Partnering Among Pharma, BioPharma, Diagnostics, and Medical Device Companies – the New Deal?